1 Invasive and non-invasive quantification of myocardial fibrosis in primary mitral regurgitation: prognostic implications for post-operative remodelling, symptom burden and exercise capacity

Boyang Liu, K. Khin, D. Neil, M. Bhabra, Ramesh L. Patel, T. Barker, N. Nikolaidis, S. Billing, T. Treibel, J. Moon, Arantxa González, James Hodosn, N. Edwards, R. Steeds
{"title":"1 Invasive and non-invasive quantification of myocardial fibrosis in primary mitral regurgitation: prognostic implications for post-operative remodelling, symptom burden and exercise capacity","authors":"Boyang Liu, K. Khin, D. Neil, M. Bhabra, Ramesh L. Patel, T. Barker, N. Nikolaidis, S. Billing, T. Treibel, J. Moon, Arantxa González, James Hodosn, N. Edwards, R. Steeds","doi":"10.1136/HEARTJNL-2020-BCS.1","DOIUrl":null,"url":null,"abstract":"Chronic primary mitral regurgitation (MR) exposes the left ventricle (LV) to volume overload and is associated with evidence of fibrosis on non-invasive imaging. It is not known whether fibrosis predicts outcome from surgery. This study aimed to 1) quantify myocardial fibrosis on histology and non-invasive imaging, 2) investigate any association between fibrosis and LV size and function, 3) determine the impact of fibrosis on post-operative outcome. Methods In a prospective observational multicentre study, 105 patients with severe MR (N=65/32/8 NYHA Class I/II/III respectively; mean age 63.1±13.4years; male 73%; VO2max 91.2±22.4%) had multiparametric cardiac magnetic resonance (CMR), symptom assessment (Minnesota Living with Heart Failure Questionnaire (MLHFQ)) and cardiopulmonary exercise testing before and at 6-9 months following repair. Patients consented for up to 3 intraoperative LV biopsies for histological collagen volume fraction (CVF) quantification. Results 234 LV biopsies were collected from 86 patients with median CVF of 14.6%[IQR 7.4-20.3]. Fibrosis was present even in NYHA Class I patients (13.6%[6.3-18.8]), and was significantly higher than the 3.3%[2.6-6.1] obtained from 8 autopsy controls without cardiac disease (P Pre-operatively, there was no relationship between CVF and LV size, systolic function, ECV, late gadolinium enhancement, although CVF did correlate with MLHFQ (R=0.23, P=0.034). Conversely, ECV correlated with systolic (LVEF Rho=-0.22, P=0.029; LVESVi Rho 0.22, P=0.025, GCS Rho=0.31, P=0.002) and diastolic function (E/e’ R=0.25, P=0.022), exercise capacity (%VO2max R=-0.22, P=0.030), with borderline correlation to MLHFQ (R=0.19, P=0.058). Following surgery, although LVEF remained >50% in all but 6 patients (LVEF pre 69.1±8.0 vs post 63.3±8.3%, P Conclusions Myocardial fibrosis is present in primary MR, before the onset of symptoms. Due to its patchy nature, ECV but not fibrosis on histology is a better marker of pre-operative myocardial function and symptom status. Despite ECV reduction following successful MR surgery, symptomatic patients fail to regain exercise fitness and symptom-free status – providing further support for the benefits of early surgery. Conflict of Interest None","PeriodicalId":152114,"journal":{"name":"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/HEARTJNL-2020-BCS.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic primary mitral regurgitation (MR) exposes the left ventricle (LV) to volume overload and is associated with evidence of fibrosis on non-invasive imaging. It is not known whether fibrosis predicts outcome from surgery. This study aimed to 1) quantify myocardial fibrosis on histology and non-invasive imaging, 2) investigate any association between fibrosis and LV size and function, 3) determine the impact of fibrosis on post-operative outcome. Methods In a prospective observational multicentre study, 105 patients with severe MR (N=65/32/8 NYHA Class I/II/III respectively; mean age 63.1±13.4years; male 73%; VO2max 91.2±22.4%) had multiparametric cardiac magnetic resonance (CMR), symptom assessment (Minnesota Living with Heart Failure Questionnaire (MLHFQ)) and cardiopulmonary exercise testing before and at 6-9 months following repair. Patients consented for up to 3 intraoperative LV biopsies for histological collagen volume fraction (CVF) quantification. Results 234 LV biopsies were collected from 86 patients with median CVF of 14.6%[IQR 7.4-20.3]. Fibrosis was present even in NYHA Class I patients (13.6%[6.3-18.8]), and was significantly higher than the 3.3%[2.6-6.1] obtained from 8 autopsy controls without cardiac disease (P Pre-operatively, there was no relationship between CVF and LV size, systolic function, ECV, late gadolinium enhancement, although CVF did correlate with MLHFQ (R=0.23, P=0.034). Conversely, ECV correlated with systolic (LVEF Rho=-0.22, P=0.029; LVESVi Rho 0.22, P=0.025, GCS Rho=0.31, P=0.002) and diastolic function (E/e’ R=0.25, P=0.022), exercise capacity (%VO2max R=-0.22, P=0.030), with borderline correlation to MLHFQ (R=0.19, P=0.058). Following surgery, although LVEF remained >50% in all but 6 patients (LVEF pre 69.1±8.0 vs post 63.3±8.3%, P Conclusions Myocardial fibrosis is present in primary MR, before the onset of symptoms. Due to its patchy nature, ECV but not fibrosis on histology is a better marker of pre-operative myocardial function and symptom status. Despite ECV reduction following successful MR surgery, symptomatic patients fail to regain exercise fitness and symptom-free status – providing further support for the benefits of early surgery. Conflict of Interest None
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1原发性二尖瓣返流心肌纤维化的有创和无创量化:对术后重构、症状负担和运动能力的预后影响
慢性原发性二尖瓣反流(MR)使左心室(LV)容量过载,并在无创成像上与纤维化证据相关。目前尚不清楚纤维化是否能预测手术结果。本研究旨在1)从组织学和无创影像学上量化心肌纤维化,2)探讨纤维化与左室大小和功能之间的关系,3)确定纤维化对术后预后的影响。方法在一项前瞻性多中心观察研究中,105例严重MR患者(N=65/32/8, NYHA I/II/III级;平均年龄63.1±13.4岁;男性73%;VO2max(91.2±22.4%)在修复前和修复后6-9个月进行多参数心脏磁共振(CMR)、症状评估(明尼苏达州心力衰竭患者问卷(MLHFQ))和心肺运动测试。患者同意术中至多3次左室活检,用于组织学胶原体积分数(CVF)量化。结果86例患者共行234例左室活检,中位CVF为14.6%[IQR 7.4-20.3]。即使在NYHA I级患者中也存在纤维化(13.6%[6.3-18.8]),显著高于8名无心脏病的尸检对照组(3.3%[2.6-6.1])(P术前,CVF与左室大小、收缩功能、ECV、晚期钆增强没有关系,尽管CVF与MLHFQ相关(R=0.23, P=0.034)。相反,ECV与收缩压相关(LVEF Rho=-0.22, P=0.029;LVESVi Rho= 0.22, P=0.025, GCS Rho=0.31, P=0.002),舒张功能(E/ E ' R=0.25, P=0.022),运动能力(%VO2max R=-0.22, P=0.030),与MLHFQ有临界相关性(R=0.19, P=0.058)。手术后,除6例患者外,所有患者的LVEF均>50% (LVEF前69.1±8.0 vs后63.3±8.3%),P结论:在症状出现之前,原发性MR中存在心肌纤维化。由于其斑块性,ECV而非纤维化在组织学上是术前心肌功能和症状状态的较好标志物。尽管成功的MR手术后ECV降低,但有症状的患者无法恢复运动能力和无症状状态,这进一步支持了早期手术的益处。利益冲突无
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
31 Case report: a new diagnosis of heterotaxy syndrome with left isomerism and pulmonary hypertension in an older adult 21 The effect of surgical scar on spirometry at cardiopulmonary exercise testing for adult congenital heart disease patients 29 Demographic characteristics of TOF patients who underwent PVS; Northern Irish experience 16 Screening for and monitoring fontan-associated liver disease in a tertiary centre 4 Cardiac power and power reserve are impaired in asymptomatic patients with aortic stenosis and associated with exercise capacity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1